Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 1,794

Document Document Title
WO/2006/136564A1
Compounds of general formula (I): in which: R1, R2, R3, R4, R5 and FG are as defined in the specification and claims, optionally conjugated with a suitable molecule able to interact with physiological systems; and their chelates with bi-...  
WO/2006/120133A2
The present invention concerns coloring keratin fibers, especially human hair, with colored metal complexes.  
WO2005117907A3
Chiral ligands and metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The metal complexes according to the present invention are useful as catalysts in asymmetric reactions, such as, hydrogenation,...  
WO/2006/080993A1
This invention relates to novel cationic crown-ether containing metal complexes, methods of preparing the cationic crown-ether containing metal complexes, and radiopharmaceutical compositions comprising the cationic crown-ether containin...  
WO2006032780A8
The invention concerns compounds of formula (I) and their use as catalyst.  
WO2006037988A3
Novel radioactive technetium and rhenium complexes comprising tripodal ligands are provided by the present invention. In particular, Tc(I) complexes are provided by the present invention. Novel ligands suitable for the formation of the t...  
WO/2006/054466A1
A radioactive technetium complex that realizes enhancing of in a single photon discharge type tomogram, cardiac contrast and initial circulation extraction ratio; and a radioactive imaging diagnostic agent comprising the complex. The com...  
WO2005068074A3
The invention accordingly relates to the use as catalysts of at least one metal complex of formula (1) [LnMemXp]2Yq (1), wherein L is a ligand of formula (2) wherein Q1 is N or CR 10, Q2 is N or CR11, and wherein the remaining substituen...  
WO/2006/043110A1
Complex salts, based on ionic liquids, which exhibit at least one light emitting property selected from (a) fluorescence, (b) phosphorescence, and (c) electroluminescence when in the solid state; and which have a melting point below 250°C.  
WO/2006/041056A1
Disclosed is a metal-containing coordination compound represented by the formula (1) below and having characteristics equivalent to or better than those of metal complexes which can be polymerized or dissolved in a solvent. Also disclose...  
WO/2006/037988A2
Novel radioactive technetium and rhenium complexes comprising tripodal ligands are provided by the present invention. In particular, Tc(I) complexes are provided by the present invention. Novel ligands suitable for the formation of the t...  
WO/2006/032780A1
The invention concerns compounds of formula (I) and their use as catalyst.  
WO/2006/026855A1
The invention provides a method for manufacturing or preparing neutral, low molecular weight 99mTc-labeled and 186Re-labeled carbohydrate complexes with an improved radiochemical yield from a simple functionalized sugar, such as glucosam...  
WO/2006/024493A1
The invention relates to a novel method for producing organorhenium(VII) oxides  
WO/2006/015414A1
The present invention provides an IR-absorbing naphthalocyanine dye of formula (I): wherein M is selected from Si(A1)(A2), Ge(A1)(A2), Ga(A1), Mg, Al(A1), TiO, Ti(A1)(A2), ZrO, Zr(A1)(A2), VO, V(A1)(A2), Mn, Mn(A1), Fe, Fe(A1), Co, Ni, C...  
WO2005097123A3
The present invention relates to Pyridyl-Substituted Porphyrin Compounds, compositions comprising an effective amount of a Pyridyl-Substituted Porphyrin Compound and methods for treating or preventing injury due to exposure to a reactive...  
WO2005097808A3
Polyhydroxy hydrogensulfated trimetallic nitride endohedral metallofullerenes, can be utilized in a number of applications, for example, as proton conductors in electrochemical devices. The presence of encapsulated metal atoms, preferabl...  
WO2005077962A3
Compositions containing crowned dithiocarbamate metal complexes and methods of using these compositions; neutral and cationic radioactive metal-nitrido complexes of crowned dithiocarbamates (DTCs) and methods of using these complexes as ...  
WO/2005/117907A2
Chiral ligands and metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The metal complexes according to the present invention are useful as catalysts in asymmetric reactions, such as, hydrogenation,...  
WO/2005/116039A1
The present invention provides a novel class of molecular coordination compounds, and more particularly, square supramolecular metal coordination grids of the formula (I): [Ma2(L)2a]Xz (I), wherein M is a transition metal: a is 3, 4, 5 o...  
WO/2005/108330A1
The aim of the invention is to provide radiolytically and metabolically stable metal complexes, which are suitable for conjugation with biomolecules and to provide a method for their production. This is achieved by metal complexes based ...  
WO/2005/105303A1
The present invention relates to the use of certain manganese complexes having bispyridylpyrimidine or bispyridyltriazine ligands or mixtures of such ligands as catalysts for reactions with peroxy compounds for bleaching coloured stains ...  
WO/2005/097808A2
Polyhydroxy hydrogensulfated trimetallic nitride endohedral metallofullerenes, can be utilized in a number of applications, for example, as proton conductors in electrochemical devices. The presence of encapsulated metal atoms, preferabl...  
WO/2005/097123A2
The present invention relates to Pyridyl-Substituted Porphyrin Compounds, compositions comprising an effective amount of a Pyridyl-Substituted Porphyrin Compound and methods for treating or preventing injury due to exposure to a reactive...  
WO/2005/090371A1
A transition metal complex which is a bis-arylimine pyridine MXn complex, comprising a bis-arylimine pyridine ligand having the formula (I), wherein R1-R5, R7-R9, R12 and R14 are each, independently, hydrogen, optionally substituted hydr...  
WO/2005/087697A1
[PROBLEMS] To provide a metal complex capable of being suitably used for manufacturing a metal-containing thin film by the CVD method and a method for manufacturing a metal-containing thin film. [MEANS FOR SOLVING PROBLEMS] A metal compl...  
WO/2005/082894A1
The present invention relates to cell targeting conjugates and in particular, but not exclusively, to methods of their use in selectively eliminating and in selectively imaging target cells. The invention also relates to processes for pr...  
WO2005067388A3
The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention fur...  
WO/2005/079865A1
One aspect of the invention relates to complexes of a radionuclide with various heteroaryl ligands, e.g., imidazolyl and pyridyl ligands, and their use in radiopharmaceuticals for a variety of clinical diagnostic and therapeutic applicat...  
WO/2005/079866A1
One aspect of the invention relates to complexes of technetium (Tc) and rhenium (Re) with various heteroaromatic ligands, e.g., quinolinyl and isoquinolinyl ligands, and their use in fluoresence and radioimaging for a variety of clinical...  
WO/2005/077962A2
Compositions containing crowned dithiocarbamate metal complexes and methods of using these compositions; neutral and cationic radioactive metal-nitrido complexes of crowned dithiocarbamates (DTCs) and methods of using these complexes as ...  
WO/2005/067388A2
The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention fur...  
WO/2005/068074A2
The invention accordingly relates to the use as catalysts of at least one metal complex of formula (1) [LnMemXp]2Yq (1), wherein L is a ligand of formula (2) wherein Q1 is N or CR 10, Q2 is N or CR11, and wherein the remaining substituen...  
WO2005033119A9
The application discloses the use of supramolecular compounds as antitumour, antimicrobial (such as antibacterial and antiprotozoal) and antiviral agents. Such compounds comprise ligands as defined in the application coordinated to at le...  
WO2004043380A8
The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tissues, organs, or tumors. In another embodiment, the invention relates the metho...  
WO/2005/044149A1
The present invention relates to hyaluronic acid polymers modified with non-proteinaceous catalysts for the dismutation of superoxide, and processes for making such materials. The invention further provides pharmaceutical compositions co...  
WO2004085497A3
This invention relates to transition metal catalyst compounds represented by the formula: LMX2 wherein M is a Group 7 to 11 metal, L is a tridentate or tetradentate neutrally charged ligand that is bonded to M by three or four nitrogen a...  
WO/2005/033119A1
The application discloses the use of supramolecular compounds as antitumour, antimicrobial (such as antibacterial and antiprotozoal) and antiviral agents. Such compounds comprise ligands as defined in the application coordinated to at le...  
WO/2005/026179A1
The invention provides ionic liquids having a secondary hydroxyl group, and an atom-efficient method for the preparation of these ionic liquids, by epoxidation of a protonated nitrogen- containing organic base (which can optionally be pr...  
WO2004106939A3
The present invention relates to a method for radioactive labeling of a protein or peptide, by providing a protein or peptide having at least one glutamine or lysine residue; adding a metal chelating agent having at least one lysine or g...  
WO2004096120A3
This invention provides new small-molecules capable of selective binding to membranes comprising and exposing phosphatidylserine on their surface and / or membranes which have increased amounts of phosphatidylethanolamine in their outer ...  
WO/2005/009963A1
Chelants and macrocyclic metal complexes thereof, methods of preparing the chelants and macrocyclic metal complexes, and radiopharmaceutical compositions comprising the macrocyclic metal complexes are disclosed. Methods of using the macr...  
WO/2005/003126A1
Diarylethene-containing ligands and their coordination compounds are described. The ligands display photochromism with UV excitation, while the coordination compounds display photochromism with both excitation in the UV region and excita...  
WO2004106390A3
This invention relates to a transition metal catalyst compound represented by the formula: LMX2 or (LMX2)2 wherein each M is independently a Group 7 to 11 metal, preferably a Group 7, 8, 9 or 10 metal; each L is, independently, a trident...  
WO2004026454A3
One aspect of the present invention relates to methods of preparing enedialkylidyne complexes, enediynes, and alkyne metathesis catalysts, as well as methods of catalyzing alkyne metathesis reactions. The present invention also relates t...  
WO2004043380A3
The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tissues, organs, or tumors. In another embodiment, the invention relates the metho...  
WO/2004/106390A2
This invention relates to a transition metal catalyst compound represented by the formula: LMX2 or (LMX2)2 wherein each M is independently a Group 7 to 11 metal, preferably a Group 7, 8, 9 or 10 metal; each L is, independently, a trident...  
WO/2004/106939A2
The present invention relates to a method for radioactive labeling of a protein or peptide, by providing a protein or peptide having at least one glutamine or lysine residue; adding a metal chelating agent having at least one lysine or g...  
WO/2004/096120A2
This invention provides new small-molecules capable of selective binding to membranes comprising and exposing phosphatidylserine on their surface and / or membranes which have increased amounts of phosphatidylethanolamine in their outer ...  
WO2004044227A3
The invention provides, in a general sense, a new labeling strategy employing compounds that are are N2S2 chelates conjugated to a targeting ligand, wherein the targeting ligand is a disease cell cycle targeting compound, a tumor angioge...  

Matches 201 - 250 out of 1,794